Literature DB >> 17872873

Fusobacterium: elusive cause of life-threatening septic thromboembolism.

Winson Y Cheung1, Jonathon Bellas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17872873      PMCID: PMC2234623     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


× No keyword cloud information.
  11 in total

1.  Cerebral infarct and meningitis secondary to Lemierre's syndrome.

Authors:  Jamie R Bentham; Andrew J Pollard; Christopher A Milford; Philip Anslow; Mike G Pike
Journal:  Pediatr Neurol       Date:  2004-04       Impact factor: 3.372

Review 2.  The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection.

Authors:  C P Sinave; G J Hardy; P W Fardy
Journal:  Medicine (Baltimore)       Date:  1989-03       Impact factor: 1.889

3.  Lemierre syndrome: usefulness of CT in detection of extensive occult thrombophlebitis.

Authors:  K V Nguyen-Dinh; K Marsot-Dupuch; F Portier; B Lamblin; P Lasjaunias
Journal:  J Neuroradiol       Date:  2002-06       Impact factor: 3.447

4.  Lemierre's syndrome: new insights into an old disease.

Authors:  J R Stallworth; J M Carroll
Journal:  Clin Pediatr (Phila)       Date:  1997-12       Impact factor: 1.168

Review 5.  Lemierre's syndrome: three cases and a review.

Authors:  Hans Dool; Robin Soetekouw; Marieke van Zanten; Edward Grooters
Journal:  Eur Arch Otorhinolaryngol       Date:  2004-12-15       Impact factor: 2.503

Review 6.  Human necrobacillosis, with emphasis on Lemierre's syndrome.

Authors:  L Hagelskjaer Kristensen; J Prag
Journal:  Clin Infect Dis       Date:  2000-09-14       Impact factor: 9.079

Review 7.  The evolution of Lemierre syndrome: report of 2 cases and review of the literature.

Authors:  Julio A Chirinos; Daniel M Lichtstein; Javier Garcia; Leonardo J Tamariz
Journal:  Medicine (Baltimore)       Date:  2002-11       Impact factor: 1.889

Review 8.  Lemierre syndrome: a complication of acute pharyngitis.

Authors:  A Williams; M Nagy; J Wingate; L Bailey; M Wax
Journal:  Int J Pediatr Otorhinolaryngol       Date:  1998-09-15       Impact factor: 1.675

9.  [Lemierre syndrome variant: Hepatic abscesses and hepatic venous thrombosis due to Fusobacterium nucleatum septicemia].

Authors:  K Le Roux; P Sève; E Gomard; A Boibieux; C Beziat; K Stankovic; C Broussolle
Journal:  Rev Med Interne       Date:  2006-01-18       Impact factor: 0.728

10.  Lemierre syndrome: the forgotten disease.

Authors:  C L Weesner; J E Cisek
Journal:  Ann Emerg Med       Date:  1993-02       Impact factor: 5.721

View more
  5 in total

1.  Liver abscess due to Fusobacterium species detected on ultrasonography: a case report.

Authors:  Vasanthapriya Subramaniyam; Akiko Saito; Katsutoshi Tokushige
Journal:  J Med Ultrason (2001)       Date:  2018-04-03       Impact factor: 1.314

2.  Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity.

Authors:  Yann Fardini; Xiaowei Wang; Stéphanie Témoin; Stanley Nithianantham; David Lee; Menachem Shoham; Yiping W Han
Journal:  Mol Microbiol       Date:  2011-11-15       Impact factor: 3.501

Review 3.  Fusobacterial liver abscess: a case report and review of the literature.

Authors:  Dilip Jayasimhan; Linus Wu; Paul Huggan
Journal:  BMC Infect Dis       Date:  2017-06-20       Impact factor: 3.090

4.  Case report of atypical Lemierre's Syndrome associated with Fusobacterium nucleatum infection without internal or external jugular venous thrombophlebitis.

Authors:  Haidang D Nguyen; Patricia N Whitley-Williams; Lakshmi P Uppaluri; Jay Sangani; Mitchell L Simon; Aisha S Baig
Journal:  Respir Med Case Rep       Date:  2022-04-18

5.  Fusobacterium nucleatum Activates Endoplasmic Reticulum Stress to Promote Crohn's Disease Development via the Upregulation of CARD3 Expression.

Authors:  Pan Cao; Yongyu Chen; Xufeng Guo; Yan Chen; Wenhao Su; Na Zhan; Weiguo Dong
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.